Q4 2025 Doximity Inc Earnings Call Transcript
Key Points
- Doximity Inc (DOCS) reported $138 million in revenue for Q4 2025, exceeding the high end of their guidance by 4%.
- The company achieved a 20% year-over-year revenue growth for the full fiscal year, reaching $570 million.
- Adjusted EBITDA margin for Q4 was 50%, surpassing guidance by 10%, and for the full year, it was 55%, up from 48% the previous year.
- Unique active users across all timeframes hit new highs, with significant growth in their news feed and AI tools.
- Doximity's integrated offerings and AI-powered tools are gaining traction, leading to larger deal sizes and improved client engagement.
- Despite strong performance, Doximity Inc (DOCS) is cautious about potential macroeconomic uncertainties affecting future growth.
- The company anticipates a tougher year-over-year comparison for fiscal 2026 due to the strategic shift in program launches.
- There is a reliance on a small number of large clients, with the top 20 customers contributing significantly to revenue growth.
- The market growth rate for the pharma HCP digital market is expected to be on the lower end of the 5% to 7% range.
- Doximity Inc (DOCS) is still in the early stages of AI investment, and the long-term impact on margins and efficiency remains uncertain.
Good day, everyone, and welcome to the Doximity Q4 2025 earnings call. At this time, I will hand the call over to Perry Gold, Head of IR. Please go ahead, sir.
Thank you, operator. Hello, and welcome to Doximity's Fiscal 2025 fourth quarter earnings call. With me on the call today are Jeff Tangney, Co-Founder and CEO of Doximity; Dr. Nate Gross, Co-Founder and CSO; and Anna Bryson, CFO. A complete disclosure of our results can be found in our press release issued earlier today as well as in our related Form 8-K, along with a copy of our prepared remarks, all available on our website at investors.doximity.com.
As a reminder, today's call is being recorded, and a replay will be available on our website. As part of our comments today, we will be making forward-looking statements. These statements are based on management's current views, expectations and assumptions and are subject to various risks and uncertainties.
Actual results may differ materially, and we disclaim any obligation to update any
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

